Patents by Inventor Aaron Peng

Aaron Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240016538
    Abstract: A method and apparatus are disclosed for a probe for forming a lesion in a target tissue. The probe comprises an elongate member with a distal tip and a proximal end. The elongate member defines a lumen therebetween which circulates cooling fluid. The probe further includes at least one active portion configured to deliver energy to the target tissue and at least one orifice. A portion of the cooling fluid is ejected from the at least one orifice to cool the target tissue and the remainder is internally circulated through the lumen of the probe.
    Type: Application
    Filed: September 14, 2021
    Publication date: January 18, 2024
    Inventors: Neil Godara, Robert Harrison, Ahmad Dastjerdi, Abelardo Escoto, Aaron Peng, Andrew Oldham, Jimmy Huynh, Ryan Li
  • Publication number: 20110123625
    Abstract: Provided are lipidic particles comprising phosphatidylcholine, phosphatidylinositol and cholesterol. Also provided are compositions comprising the lipidic particles and having associated therewith therapeutic agents such as peptides, polypeptides or proteins. In these compositions, the therapeutic agents have reduced immunogenicity and/or longer circulating time. These compositions can be used for therapeutic administration of the peptides, polypeptides and/or proteins.
    Type: Application
    Filed: December 28, 2010
    Publication date: May 26, 2011
    Inventors: Sathy V. Balu-Iyer, Robert M. Straubinger, Razvan Miclea, Aaron Peng
  • Patent number: 7875289
    Abstract: Provided are lipidic particles comprising phosphatidylcholine, phosphatidylinositol and cholesterol. Also provided are compositions comprising the lipidic particles and having associated therewith therapeutic agents such as peptides, polypeptides or proteins. In these compositions, the therapeutic agents have reduced immunogenicity and/or longer circulating time. These compositions can be used for therapeutic administration of the peptides, polypeptides and/or proteins.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: January 25, 2011
    Assignee: The Research Foundation of State University of New York
    Inventors: Sathy V. Balu-Iyer, Robert M. Straubinger, Razvan Miclea, Aaron Peng
  • Patent number: 7875288
    Abstract: Provided is a method for treatment of blood coagulation disorders. The method comprises administering to an individual compositions comprising lipidic particles comprising phosphatidylcholine, phosphatidylinositol and cholesterol. One or more peptides, polypeptides or proteins involved in the blood coagulation cascade are associated with the lipidic particles.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: January 25, 2011
    Assignee: The Research Foundation of State University of New York
    Inventors: Sathy V. Balu-Iyer, Robert M. Straubinger, Razvan Miclea, Aaron Peng
  • Publication number: 20070275050
    Abstract: Provided is a method for treatment of blood coagulation disorders. The method comprises administering to an individual compositions comprising lipidic particles comprising phopatidylcholine, phosphatidylinositol and cholesterol. One or more peptides, polypeptides or proteins involved in the blood coagulation cascade are associated with the lipidic particles.
    Type: Application
    Filed: March 30, 2007
    Publication date: November 29, 2007
    Inventors: Sathy Balu-Iyer, Robert Straubinger, Razvan Miclea, Aaron Peng
  • Publication number: 20070274980
    Abstract: Provided are lipidic particles comprising phopatidylcholine, phosphatidylinositol and cholesterol. Also provided are compositions comprising the lipidic particles and having associated therewith therapeutic agents such as peptides, polypeptides or proteins. In these compositions, the therapeutic agents have reduced immunogenicity and/or longer circulating time. These compositions can be used for therapeutic administration of the peptides, polypeptides and/or proteins.
    Type: Application
    Filed: March 30, 2007
    Publication date: November 29, 2007
    Inventors: Sathy Balu-Iyer, Robert Straubinger, Razvan Miclea, Aaron Peng